121 related articles for article (PubMed ID: 17493308)
1. Resource use and costs associated with different states of breast cancer.
Lidgren M; Wilking N; Jönsson B; Rehnberg C
Int J Technol Assess Health Care; 2007; 23(2):223-31. PubMed ID: 17493308
[TBL] [Abstract][Full Text] [Related]
2. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
3. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
5. Cost of radiotherapy in Sweden.
Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
[TBL] [Abstract][Full Text] [Related]
6. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
7. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Sorensen SV; Goh JW; Pan F; Chen C; Yardley D; Martín M; Knopf K; Benedict A; Giorgetti C; Iyer S
Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
[TBL] [Abstract][Full Text] [Related]
8. The economic consequences of asthma among adults in Sweden.
Jansson SA; Rönmark E; Forsberg B; Löfgren C; Lindberg A; Lundbäck B
Respir Med; 2007 Nov; 101(11):2263-70. PubMed ID: 17689234
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer--prevalence-based healthcare costs.
Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
[TBL] [Abstract][Full Text] [Related]
10. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
Malmberg I; Persson U; Ask A; Tennvall J; Abrahamsson PA
Urology; 1997 Nov; 50(5):747-53. PubMed ID: 9372886
[TBL] [Abstract][Full Text] [Related]
11. [Advanced breast cancer: an evaluation of the cost of recurrence].
Bercez C; Lebrun T; Bonneterre ME; Selke B; Lenne X; Bonneterre J
Bull Cancer; 1999 Jun; 86(6):585-90. PubMed ID: 10417432
[TBL] [Abstract][Full Text] [Related]
12. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
[TBL] [Abstract][Full Text] [Related]
13. Costs in primary care of investigating symptoms suspicious of cancer in a defined population.
Månsson J; Marklund B; Carlsson P
Scand J Prim Health Care; 2006 Dec; 24(4):243-50. PubMed ID: 17118865
[TBL] [Abstract][Full Text] [Related]
14. Direct and indirect costs in a prospective cohort of patients with pancreatic cancer.
Müller-Nordhorn J; Brüggenjürgen B; Böhmig M; Selim D; Reich A; Noesselt L; Roll S; Wiedenmann B; Willich SN
Aliment Pharmacol Ther; 2005 Sep; 22(5):405-15. PubMed ID: 16128678
[TBL] [Abstract][Full Text] [Related]
15. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
16. The burden of prenatal exposure to alcohol: revised measurement of cost.
Stade B; Ali A; Bennett D; Campbell D; Johnston M; Lens C; Tran S; Koren G
Can J Clin Pharmacol; 2009; 16(1):e91-102. PubMed ID: 19168935
[TBL] [Abstract][Full Text] [Related]
17. Diabetes: the cost of illness in Sweden.
Henriksson F; Jönsson B
J Intern Med; 1998 Dec; 244(6):461-8. PubMed ID: 9893099
[TBL] [Abstract][Full Text] [Related]
18. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden.
Jacobsson LT; Lindroth Y; Marsal L; Juran E; Bergström U; Kobelt G
Scand J Rheumatol; 2007; 36(3):179-83. PubMed ID: 17657670
[TBL] [Abstract][Full Text] [Related]
20. Cost of heart failure in Swedish primary healthcare.
Agvall B; Borgquist L; Foldevi M; Dahlström U
Scand J Prim Health Care; 2005 Dec; 23(4):227-32. PubMed ID: 16272071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
